🇺🇸 FDA
Patent

US 8017619

Compositions useful as inhibitors of protein kinases

granted A61KA61K31/496A61P

Quick answer

US patent 8017619 (Compositions useful as inhibitors of protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Sep 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
45
CPC classes
A61K, A61K31/496, A61P, A61P1/04, A61P1/16